Repligen Appeals Ruling in Dispute with Bristol-Myers

Law360, New York (October 10, 2003, 12:00 AM EDT) -- Biotech company Repligen Corporation has appealed the ruling in its lawsuit against Bristol-Myers Squibb, the company said in a statement.

In September, the United States District Court for the Eastern District of Michigan ruled that there was insufficient evidence for a university scientist to be named as an inventor on these patents. The lawsuit was filed by Repligen and the University of Michigan.

The dispute concerns key patents regarding a compound now in testing for rheumatoid arthritis. It dates back to a now-defunct research collaboration between...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.